Skip to main content
Premium Trial:

Request an Annual Quote

Most Viewed Articles on GWDN Last Week: Dec 8, 2014

NEW YORK (GenomeWeb News) — What articles gained the most interest from GenomeWeb readers last week? Here are the top five:

1)            Roche to Acquire Ariosa Diagnostics to Gain Foothold in NIPT, Cell-free DNA Testing Markets

2)            Illumina, Sequenom Pool NIPT Patents, Settling IP Disputes

3)            LabCorp Acquires Bode Technology

4)            Study of Twins Starts Unraveling Genetic, Environmental Contributors to Gene Regulation

5)            23andMe Gets CE Mark, Launches PGS Offering in UK for £125

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.